Couch potato? It could be genetic

February 14, 2014 by Jennifer Phillips
Scientists in China and Aberdeen have made a key discovery which could explain why some people are ‘couch potatoes’.

(Medical Xpress)—Scientists in China and Aberdeen have made a key discovery which could explain why some people are 'couch potatoes'.

They have found that a mutation in a gene, which has a critical role in the brain, may explain why some people are less inclined to exercise and are more likely to put on weight and develop health problems.

Their study - published in PLOS Genetics - also raises the prospect that in the future there could be a personalised pill that could reverse the problem.

Scientists from the Chinese Academy of Sciences, Institute of Genetics and Developmental Biology (IGDB) in Beijing and the University of Aberdeen, compared 'normal' with mice that had a mutation in a gene called SLC35D3.

The researchers discovered that SLC35D3 produces a protein which plays a key signalling role in the brain's dopamine system – this system is involved in a range of functions including regulation of .

Specifically they found that SLC35D3 seems to be important for transporting a type of dopamine receptor, from where they are made inside the cell, to the cell surface, where they can bind with dopamine.

However mice with this gene mutated had far fewer of this type of dopamine receptor on their brain cell surfaces. Instead, the were stuck within the cell. This meant that their signalling process was not functioning properly.

Professor Wei Li, of the IGDB, where all the work was carried out, led the study. He said: "We discovered that mice with this gene mutation were typical couch potatoes. They walked only about a third as much as a normal mouse, and when they did move they walked more slowly. The mice became fat and they also developed other symptoms similar to a condition in people called 'metabolic syndrome' - a medical term for those with a combination of risk factors related to diabetes, and obesity."

Professor John Speakman, who works between the University of Aberdeen and the IGDB, and was a co-author on the paper, said: "We discovered that SLC35D3 plays a critical role in transporting the dopamine 1 receptor from where it is made inside the cell, to the . Hence dopamine signalling in the mutant mice was significantly impaired."

Professor Li added: "What was of particular interest, was that what that when we gave the mice a drug that acted on the dopamine signalling system, the genetic defect could be overcome and the mice became more active and thinner."

The researchers then screened 400 overweight and obese Chinese patients with metabolic syndrome and found mutations in the SLC35D3 gene in two of them.

As the mice could be treated using a drug that acted on the dopamine receptor, the scientists suggest that in the future people with metabolic syndrome could possibly be screened to see if they have the relevant mutations. If so, perhaps drugs could be offered as a treatment.

Professor Li said: "We are really excited about these findings. A long-standing prescription in combating obesity is to mind your mouth and move your legs. However, genetics contributes to the reluctance to move in some obese people. Medical treatments will in the future be tailored to fit a person's individual genetic make-up."

Professor Speakman added: "Although only about one in about 200 people may have these 'rare' mutations, there are a very large number of people worldwide that have . Consequently the population of sufferers that may benefit from being treated with dopamine receptor drugs runs into many millions of patients. The work is a perfect example of successful translational work – from great basic science to an important potential clinical application."

Explore further: Researchers find rare genetic cause of Tourette syndrome

More information: Zhang Z, Hao C-J, Li C-G, Zang D-J, Zhao J, et al. (2014) "Mutation of SLC35D3 Causes Metabolic Syndrome by Impairing Dopamine Signaling in Striatal D1 Neurons." PLoS Genet 10(2): e1004124. DOI: 10.1371/journal.pgen.1004124

Related Stories

Researchers find rare genetic cause of Tourette syndrome

January 9, 2014
A rare genetic mutation that disrupts production of histamine in the brain is a cause of the tics and other abnormalities of Tourette syndrome, according to new findings by Yale School of Medicine researchers.

New avenue to treat diabetes-related vision problems

January 22, 2014
Dopamine-restoring drugs already used to treat Parkinson's disease may also be beneficial for the treatment of diabetic retinopathy, a leading cause of blindness in adults, researchers have discovered.

New risk factor found for schizophrenia

February 6, 2014
(Medical Xpress)—Scientists have discovered a link between a largely unstudied gene and schizophrenia.

Histamine control of Tourette syndrome

January 17, 2014
(Medical Xpress)—Like narcolopsy, Tourettes syndrome is as much an enigma to the neuroscientists that study it, as it is to its sufferers. To say that we really understand nothing about how diseases like Tourettes actually ...

Activation of a single neuron type can trigger eating

January 20, 2014
Activation of a single type of neuron in the prefrontal cortex can spur a mouse to eat more—a finding that may pinpoint an elusive mechanism the human brain uses to regulate food intake.

Neurologists finds potential route to better treatments for Fragile X, autism

October 23, 2013
When you experience something, neurons in the brain send chemical signals called neurotransmitters across synapses to receptors on other neurons. How well that process unfolds determines how you comprehend the experience ...

Recommended for you

The 16 genetic markers that can cut a life story short

July 27, 2017
The answer to how long each of us will live is partly encoded in our genome. Researchers have identified 16 genetic markers associated with a decreased lifespan, including 14 new to science. This is the largest set of markers ...

A rogue gene is causing seizures in babies—here's how scientists wants to stop it

July 26, 2017
Two rare diseases caused by a malfunctioning gene that triggers seizures or involuntary movements in children as early as a few days old have left scientists searching for answers and better treatment options.

Scientists provide insight into genetic basis of neuropsychiatric disorders

July 21, 2017
A study by scientists at the Children's Medical Center Research Institute at UT Southwestern (CRI) is providing insight into the genetic basis of neuropsychiatric disorders. In this research, the first mouse model of a mutation ...

Scientists identify new way cells turn off genes

July 19, 2017
Cells have more than one trick up their sleeve for controlling certain genes that regulate fetal growth and development.

South Asian genomes could be boon for disease research, scientists say

July 18, 2017
The Indian subcontinent's massive population is nearing 1.5 billion according to recent accounts. But that population is far from monolithic; it's made up of nearly 5,000 well-defined sub-groups, making the region one of ...

Mutant yeast reveals details of the aberrant genomic machinery of children's high-grade gliomas

July 18, 2017
St. Jude Children's Research Hospital biologists have used engineered yeast cells to discover how a mutation that is frequently found in pediatric brain tumor high-grade glioma triggers a cascade of genomic malfunctions.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.